Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$5000.0.

  • Angiodynamics' Tax Provisions rose 9545.45% to -$5000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$2000.0, marking a year-over-year increase of 9998.42%. This contributed to the annual value of -$39000.0 for FY2025, which is 9946.49% up from last year.
  • As of Q4 2025, Angiodynamics' Tax Provisions stood at -$5000.0, which was up 9545.45% from $65000.0 recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Tax Provisions registered a high of $16.4 million during Q4 2023, and its lowest value of -$12.0 million during Q1 2024.
  • For the 5-year period, Angiodynamics' Tax Provisions averaged around -$785950.0, with its median value being -$483500.0 (2021).
  • Its Tax Provisions has fluctuated over the past 5 years, first soared by 300796.46% in 2023, then crashed by 660614.53% in 2024.
  • Angiodynamics' Tax Provisions (Quarter) stood at -$512000.0 in 2021, then fell by 10.35% to -$565000.0 in 2022, then skyrocketed by 3007.96% to $16.4 million in 2023, then plummeted by 100.67% to -$110000.0 in 2024, then skyrocketed by 95.45% to -$5000.0 in 2025.
  • Its Tax Provisions was -$5000.0 in Q4 2025, compared to $65000.0 in Q3 2025 and -$60000.0 in Q2 2025.